Interventional therapy is changing the way we treat dry eye disease (DED), giving eye care professionals a more active role in dry eye management and improving the overall patient experience.

Lumenis® is a global leader in medical lasers and light-based technologies and continuously develops state-of-the-art products that redefine treatment performance. The primary principal behind lasers and light based technologies is selective photothermolysis (abbreviated SPTL) which is the ability to target specific chromophores (light-reactive elements) such as blood, melanin, or water using a specific wavelength or color of laser or light source. In hair removal treatments, for example, the laser targets the hair follicle (melanin chromophore) while leaving the surrounding skin (water chromophore) and blood vessels (hemoglobin chromophore) unharmed.

The Lumenis Novus Spectra® is an innovative photocoagulator with an extensive set of features that deliver power and reliability with proprietary advancements in diode-pumped solid-state technology.

Lumenis showcasing a wide range of novel technologies for skin, hair, body and women’s health applications at this year’s WCD, 11th – 14th June.

Lumenis Unveils a Wide Range of Innovative Technologies for Multiple Skin and Body Applications at the 2019 American Academy of Dermatology (AAD) Conference

Vacuum gently draws skin into the handpiece, skin is stretched thin and target is pulled closer to the energy source. Energy is applied to target in which melanocytes are spread apart and blood flow is constricted. Target is damaged and skin is released.

A global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology & Aesthetic markets. World-renowned expert in developing & commercializing innovative energy-based technologies, including CO2 & Holmium Lasers, Intense Pulsed Light (IPL) & Radio-Frequency (RF) devices.

All-in-one, multi-application platform expanding your aesthetic offering with over 30 best-selling IPL & laser skin treatments.

Intense Pulsed Light (IPL) for dry eyes: a non-invasive solution targeting Meibomian Gland Dysfunction (MGD) to improve eye comfort, vision & quality of life.

Great clinical results begin with the LightSheer DESIRE 805 nm diode laser empowered by two advanced technologies Vacuum Assisted High-Speed Integrated Technology A large 22×35 mm spot size enables the use of low-fluence and with a unique mechanism for pain reduction provides effective, fast and comfortable treatment. ChillTip™ Technology – Integrated contact cooling provides epidermal protection for treatment areas requiring precision and higher fluence.